Clinical Trials Browser

Recurrence × Pemetrexed × Genitourinary × Clear all

NCT00035061 2006-07-19

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Phase 2 Completed

Urinary Bladder Neoplasms, Neoplasm Metastasis, Recurrence, Urologic Neoplasms